MRNA

MKT CAP:$18B

Moderna Inc

Market Cap

$18B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$47.60+$16.74 (+54.24%)

Jun 8, 2026

52W High $57.8052W Low $22.36

Company Details

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination...

CEO

—

IPO Date

Dec 7, 2018

Website

www.modernatx.com

Key Metrics TTM

Revenue

$2.2B

-29.1% YoY

Net Income

-$3.2B

EPS (Diluted)

Free Cash Flow

-$1.6B

Revenue / Share

$5.63

Gross Margin

-13.9%

Operating Margin

-153.3%

Net Margin

-143.6%

FCF Margin

-71.1%

P/S

8.2x

P/E

Earnings Reports

Q2 2026

Jul 31, 2026

PENDING

Q1 2026

May 1, 2026

$389M+263.6%

FY 2025

Feb 20, 2026

$1.9B-39.2%

Q4 2025

Feb 20, 2026

$678M-29.1%

Q3 2025

Nov 6, 2025

$1.0B-45.2%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee